ImmunoCellular Therapeutics, Ltd. 4
4 · ImmunoCellular Therapeutics, Ltd. · Filed Sep 24, 2013
Insider Transaction Report
Form 4
Singhvi Rahul
Director
Transactions
- Award
Stock Option (right to buy)
2013-09-20+70,000→ 70,000 totalExercise: $2.70Exp: 2020-09-19→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option vests in equal quarterly installments for four years following September 20, 2013.